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Abstract
Introduction Nocardial arthritis in immunocompetent
patients is rare, and the optimum duration of antimicrobial
therapy is unknown, although several months of antibiotic
treatment is often recommended.
Case report We here report the first case of human
infection with a novel Nocardia sp., summarise the epi-
demiology of nocardial arthritis and outline the feasibility
of relatively short antibiotic treatments after careful sur-
gical drainage.
Keywords Arthritis  Cotrimoxazole  Nocardia 
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Introduction
Nocardia spp are aerobic Gram-positive bacteria that are
considered to be ubiquitous soil saprophytes [1]. The genus
encompasses more than 20 species [2], and new species are
continuously being identified [2]. Human infections caused
by Nocardia spp often appear as pneumonia [2] or dis-
seminated diseases in severely immunocompromised hosts
[1, 3]. Cotrimoxazole remains the antibiotic of choice
[1, 3–7].
Nocardial arthritis in immunocompetent patients is very
rare. Although no studies have compared the drainage
procedure to the no-drainage procedure, the vast majority
of experts recommend joint drainage in patients with septic
arthritis [4]. In contrast, the duration of concomitant anti-
biotic treatment remains unknown only single case reports
have been published.
We report here the first human infection with a novel
Nocardia sp. that occurred as a posttraumatic arthritis in an
immunocompetent host. We further discuss the feasibility
of a relatively short antibiotic treatment after an adequate
surgical drainage procedure and review the literature.
Case report
A 40-year-old epileptic patient survived a car accident in
the Rhone Valley, France, in May 2, 2008. He suffered
open fractures (grade IIIb) of both ankles that were con-
taminated by earth, which were initially washed and then
stabilised with intramedullar nailing. The patient received
empirical antibiotic treatment of amoxicillin/clavulanate
for 5 days. After his transfer to the Geneva University
Hospitals, an elective surgical revision was necessary
because of incongruence of the articular surfaces. On May
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15, both intramedullar nails were removed, and the ankles
were stabilised with external tibio-tarsal fixation devices
(Hoffmann II) with the intention that these devices remain
in place for 6 weeks. However, on June 19, the patient
developed clinical signs of arthritis on his right ankle
(erythema, tenderness, pain) with a purulent discharge of
the scar. He had no concomitant fever, and the serum
C-reactive protein level was 52 mg/L. All external fixation
and thus all foreign material were therefore removed after
5 weeks, 1 week earlier than initially scheduled. The bone
was considered to be sufficiently consolidated so that no
new fixation was necessary on the infected ankle. The
patient was given instructions on how to discharge his leg
for another 2 months. Gram-staining and microscopic
examination of the pus did not show any pathogen or
crystal. The patient was empirically treated with intrave-
nous vancomycin 2 g/day and ceftriaxone 2 g/day. Five
days later, colonies of a Nocardia sp. appeared on micro-
biological cultures of the pus. The antibiotic treatment was
changed to intravenous cotrimoxazole (160 mg trimethro-
prim/800 mg sulfamethoxazol; three times daily) for
5 days, followed by oral cotrimoxazole 960 mg (double-
strength tablets) twice daily for a total of 8 weeks (until
August 26). The fourth and last drainage performed on July
4 revealed that the surgical site was sterile. The cure was
considered to be complete, and the patient has had no
recurrence based on a follow-up at 20 months. No under-
lying immunosuppression was detected at that time.
Microbiology
Phenotypical diagnosis
The Nocardia were cultured on Columbia agar incubated
aerobically at 35C in an atmosphere enriched with 5%
CO2 [3, 8, 9]. Laboratory examination revealed beaded/
branching, acid-fast, Gram-positive rods that were positive
for b-lactamase, glucolysis and urease production. All tests
for hydrolysis (casein, xanthine and tyrosine) were nega-
tive, as was the reduction of nitrate, growth at 45C, fer-
mentation of maltose and the test for esculin. The tests for
casein hydrolysis involved a culture period of 14 days,
those for xanthine, 3 weeks and those for tyrosine,
4 weeks.
Based on these phenotypical characteristics, the cultured
Nocardia was classified as being closest to N. beijingensis
[8, 9]. Antimicrobial minimal inhibitory concentrations
(MICs) were determined by the E test (AB Biodisk, Solna,
Sweden). The bacterium was susceptible to imipenem,
tobramycin, kanamycin, tetracyclines and cotrimoxazole
with corresponding MICs of 0.38, 1.5, 0.12, 0.064 and
0.25 mg/L, respectively.
Gene sequencing
The sequence of the 16S rRNA gene [10] was determined
by a capillary sequence analyser (ABI 3130 XL DNA
analyser; Applied Biosystems, Foster City, CA). Over a
979-bp fragment (region 49–1,027 of the 16S rRNA gene),
our strain (GenBank Accession no. GQ281125) showed
three nucleotide differences when compared to N. beij-
ingensis [2] (GenBank Accession no. AF154129) and only
one nucleotide difference with strains from Thailand and
Japan [8] (DDBJ Accession no. AB094639–AB094656).
Different sequences of Nocardia sp. and one sequence of
N. asteroides (Accession no. Z82227) were also very close
to our strain. Although sequence analysis of the 16S rRNA
gene is adequate for the identification of numerous
Nocardia sp., it is known that the speciation of some iso-
lates requires the analysis of another gene target. The gene
seqA1 has been described as a more discriminative method
[11]. With this approach, our clinical isolate had a seqA1
gene showing at least 21 mismatches over 522 bp when
compared to strains N. beijingensis, N. arthritidis or
N. abscessus.
Review of the literature
Table 1 summarises other clinical and epidemiological
aspects of the 26 published cases of nocardial arthritis we
identified in the English literature. In one-third of all cases,
nocardial arthritis presented secondary to pneumonia, and
in one-fourth it was related to a traumatic origin. The knee
joint was involved in half of the cases, and most infections
were due to N. asteroides. One-half of the patients were
immunocompromised, and male patients predominated.
Cotrimoxazole was used in two-thirds of cases, and the
average number of surgical interventions per case was 2.3.
Discussion
We report here the first case of human infection with a
novel Nocardia sp. that closely resembles N. beijingensis
phenotypically. It clearly came from the soil that pene-
trated the open fractures of the patient. In a study carried
out in 2001, N. beijingensis was detected in the soil around
Beijing [2]. In 2004, microbiologists retrospectively iden-
tified 19 human cases of N. beijingensis infection in Japan
and Thailand [8, 12]. Our phenotypical results are in
agreement with the phenotypic characteristics reported in
these earlier studies, with the exception of a negative
growth test at 45C, while the Asian study reported positive
growth. Phenotypically, N. abscessus is frequently nitrate-
positive and imipenem-resistant, N. arthritidis is nitrate





















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































positive and grows at 45C and N. beijingensis is xanthine-
positive. Our strain is also genetically close to N. astero-
ides, N. abscessus and N. beijingensis based on 16S rDNA
sequencing [10], but substantial differences were docu-
mented in the seqA1 gene [11], thus formally excluding N.
beijingensis. We found no match for our strain in GenBank
and related public databases. Therefore, we have to con-
sider this isolate as a novel Nocardia species. With the
widespread use of typing techniques and sequence-based
confirmation of unusual isolates, it is likely that this novel
strain will be encountered more than once in the future.
An important clinical message of this report is the fea-
sibility of a rather short antibiotic therapy of only
2 months, provided that adequate surgical drainage or
repetitive arthrocentesis has been performed. To date,
treatments of several months are still recommended for
nocardial arthritis due to the risk of recurrence [13] and
substantial mortality in the case of disseminated disease
[3, 14]. Our review of the literature revealed a median
treatment duration of 4 months (with the exception of our
treatment protocol), with one report of a 2-year treatment
[6]; these treatments are ubiquitously associated with high
cure rates of almost 90% (Table 1). Unfortunately, we
were unable to answer the question of whether the con-
tinuous presence of a foreign body—i.e. infection of the
joint prosthesis—with implant retention would influence
the duration of the concomitant antibiotic treatment. Most
nocardial arthritis cases involve native joints or joints with
removed osteosynthesis material.
In systemic nocardiosis, the infection usually stems from
the lungs of a severely immunocompromised host, and
arthritis is typically related to haematogenous seeding [1,
3]. Consequently, prolonged antibiotic treatment durations
are probably justified. In contrast, in immunocompetent
patients with localised posttraumatic disease in the absence
of a foreign body, one probably could combine adequate
surgical drainage or arthrocentesis with a much shorter
antibiotic course, as illustrated in this case, with 8 weeks of
therapy, or in a previous case, with 7 weeks [15]. This
combined regimen should reduce the adverse events of a
prolonged cotrimoxazole therapy [7]. However, a careful
follow-up is warranted when the duration of the antibiotic
treatment is reduced, given the paucity of experience with
this approach and the novelty of this and future strains.
Randomised trials are very likely impossible due to the
rarity of the disease, and further reports on the efficacy of
relatively short-course antibiotic treatments are clearly
warranted.
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